`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ALERE INC.
`Petitioner
`
`v.
`
`REMBRANDT DIAGNOSTICS, LP
`Patent Owner
`
`Case No. IPR2016-01498
`
`Patent No. 8,623,291
`
`PETITIONER’S MOTION FOR PRO HAC VICE ADMISSION OF J.
`ANTHONY DOWNS UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`Case No. IPR2016-01498
`
`Alere Inc. (“Petitioner”) respectfully requests the pro hac vice admission of
`
`J. Anthony Downs in this proceeding, IPR2016-01498, concerning U.S. Patent No.
`
`8,623,291 (“the ‘291 patent”), pursuant to 37 C.F.R. § 42.10(c).
`
`I.
`
`THE REQUEST IS TIMELY
`
`As stated in the Patent Trial and Appeal Board’s (“Board”) August 15, 2016
`
`Notice of Filing Date Accorded to Petition And Time For Filing Patent Owner
`
`Preliminary Response, any motion for pro hac vice admission must be filed in
`
`accordance with the guidance specified in Case IPR2013-00639 (Paper 7) (“PHV
`
`Admission Order”). According to that guidance, pro hac vice motions can be filed
`
`no sooner than (21) days after service of the Petition. This pro hac vice motion is
`
`filed more than 21 days after the service of the Petition and is therefore timely.
`
`II.
`
`STATEMENT OF FACTS
`
`As required by the PHV Admission Order, the following statement of facts
`
`show that there is good cause for the Board to recognize Mr. Downs pro hac vice.
`
`An affidavit by Mr. Downs containing the required statements and information is
`
`submitted herewith. (Ex. 1015).
`
`1. Douglas J. Kline, lead counsel for Petitioner Alere Inc. in this
`
`proceedings, is a registered practitioner holding Registration No. 35,574.
`
`2. Mr. Downs is a partner with Goodwin Procter LLP.
`
`
`
`
`1
`
`
`
`Case No. IPR2016-01498
`
`3. Mr. Downs has an established familiarity with the subject matter at
`
`issue in this proceeding. Mr. Downs has represented and continues to represent
`
`petitioner Alere Inc. and its subsidiaries Alere Toxicology Services, Inc., America
`
`Biotech, Inc., Ameditech, Inc., Innovacon, Inc., Instant Technologies, Inc., Instant
`
`Tech Subsidiary Acquisition Inc. d/b/a US Diagnostics, and Branan Medical Corp.
`
`as their lead counsel in co-pending litigation in the Southern District of California,
`
`captioned Rembrandt Diagnostics, LP v. Alere Inc., et al., No. 3:16-cv-698-CAB-
`
`NLS (“the district court litigation”) since shortly after it was filed on March 23,
`
`2016. Among other things, the district court litigation asserts infringement of the
`
`same patent at issue here, U.S. Patent No. 8,623,291.
`
`4. Mr. Downs represents that he has reviewed and analyzed the patent at
`
`issue in this proceeding, the Petition and accompanying exhibits filed in this
`
`proceeding, and all other papers associated with this proceeding. Moreover, he
`
`represents that in the district court litigation, he developed invalidity, non-
`
`infringement, and claim construction positions concerning the patent at issue here.
`
`He therefore has extensive knowledge of this patent and of the cited prior art.
`
`5. Mr. Downs is an experienced litigation attorney. Mr. Downs has been
`
`practicing law since 1986, and have been litigating patent cases for more than 15
`
`years. Mr. Downs has extensive experience litigating patent infringement cases in
`
`many different courts across the United States.
`
`
`
`
`2
`
`
`
`Case No. IPR2016-01498
`
`6. Mr. Downs’ experience in patent litigation matters includes serving as
`
`lead counsel in patent jury trials, including making opening and closing statements,
`
`presentation of non-expert and expert-testimony, arguing Markman hearings,
`
`patent summary judgment proceedings, and other patent-related hearings and
`
`preparation of pleadings concerning, inter alia, patent validity and infringement
`
`issues. Mr. Downs has also represented clients in appeals before the Court of
`
`Appeals for the Federal Circuit and the U.S. Supreme Court.
`
`7. Mr. Downs has represented petitioner Alere Inc. and/or its affiliates in
`
`many patent litigation matters since 2002, including:
`
`Name
`Alere Inc., et. al. v. Church & Dwight
`Co., Inc.
`Inverness Medical Innovations, Inc. et al.
`v. Orasure Technologies, Inc.
`Abbott Laboratories et al v. Church
`& Dwight, Inc.
`Inverness Medical, et al v.
`Quidel Corporation
`Quidel Corporation v. Inverness
`Medical, et al.
`Inverness Medical Switzerland GmbH
`et al v. Acon Laboratories, Inc.
`Inverness Medical, et al v.
`Acon Labortories, Inc.
`Inverness Medical SW, et al. v.
`Pfizer Inc., et al.
`
`
`
`
`3
`
`Filed
`January 8,
`2010
`
`April 15, 2008
`
`June 18, 2007
`
`MAD
`
`NJD
`
`ILND
`
`Number District
`1-10-cv-
`10027
`3-08-cv-
`01856
`1-07-cv-
`03428
`3-04-cv-
`00489
`3-04-cv-
`00378
`1-03-cv-
`11323
`1-02-cv-
`12303
`2-02-cv-
`01029
`
`CASD March 9, 2004
`CASD February 20,
`2004
`
`MAD
`July 15, 2003
`MAD November 26,
`2002
`
`NJD
`
`March 7, 2002
`
`
`
`Case No. IPR2016-01498
`
`Name
`Inverness Medical, et al v. Pfizer, Inc.,
`et al.
`
`Number District
`2-01-cv-
`05516
`
`NJD
`
`Filed
`November 29,
`2001
`
`
`
`8. Mr. Downs is a member in good standing of the Bar of the State of
`
`Massachusetts and admitted to practice before the U.S. Supreme Court, the U.S.
`
`Court of Appeals for the First, Second, and Federal Circuits, the District Court for
`
`the District of Massachusetts, the District Court for the Eastern District of Texas,
`
`the District Court for the Northern District of Illinois, the Massachusetts Supreme
`
`Judicial Court, and the International Trade Commission.
`
`9. Mr. Downs has never been suspended or disbarred from practice
`
`before any court or administrative body.
`
`10. No application of Mr. Downs for admission to practice before any
`
`court or administrative body has ever been denied.
`
`11. No sanctions or contempt citations have ever been imposed against
`
`Mr. Downs by any court or administrative body.
`
`12. Mr. Downs represents that he has read will comply with the Office
`
`Patent Trial Practice Guide and the Board’s Rules of Practice for Trials set forth in
`
`part 42 of 37 C.F.R.
`
`
`
`
`4
`
`
`
`Case No. IPR2016-01498
`
`13. Mr. Downs represents that he understand that he will be subject to the
`
`U.S.P.T.O. Code of Professional Conduct set forth in 37 C.P.R. §§ 10.101 et seq.
`
`and disciplinary jurisdiction under 37 C.P.R. §§ 11.19(a).
`
`14. Mr. Downs is also applying for pro hac vice admission in Case
`
`IPR2016-01502, in a concurrently filed motion, which involves a patent related to
`
`the patent at issue in the instant proceeding. Mr. Downs has not applied for pro
`
`hac vice admission in any other proceedings before the Office in the last three
`
`years.
`
`
`
`Dated: October 25, 2016
`
`Respectfully submitted,
`
`
`
`/ Douglas J. Kline /
`(Reg. No. 35,574)
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02110
`Tel: 617-523-1000
`Fax: 617-523-1231
`Email: dkline@goodwinlaw.com
`
`Counsel for Petitioner Alere Inc.
`
`
`
`
`5
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing document captioned
`
`PETITIONER’S MOTION FOR PRO HAC VICE ADMISSION OF J.
`
`ANTHONY DOWNS UNDER 37 C.F.R. § 42.10(c) was served electronically via
`
`e-mail on this 25th day of October, 2016, as follows:
`
`Joseph F. Jennings (Reg. No. 40,664)
`Jared C. Bunker (Reg. No. 58,474)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, Fourteenth Floor
`Irvine, CA 92614
`Tel: 949-760-0404
`Fax: 949-760-9502
`Email: BoxRembrandt-LP2@knobbe.com
`
`Counsel for Rembrandt Diagnostics, LP
`
`/Douglas J. Kline/
`Douglas J. Kline
`Registration No. 35,574
`GOODWIN PROCTER LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: October 25, 2016